Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea B Apolo

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Nature Reviews. Urology|September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshopElaine Chang, Andrea B Apolo, Rick Bangs, et al.
The Journal of Urology|June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsGuru Sonpavde, Juliane Manitz, Chen Gao, et al.
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Genitourinary Cancer|June 23, 2016
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial CarcinomaAndrea B Apolo, Fatima H Karzai, Jane B Trepel, et al.
AJR. American Journal of Roentgenology|October 16, 2019
Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective StudyBaris Turkbey, Marcin Czarniecki, Joanna H Shih, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer GroupAshish M Kamat, Andrea B Apolo, Marek Babjuk, et al.
JAMA Oncology|November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder CancerAndrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Urologic Oncology|August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancerMatthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2019
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder CancerVenkatrao Vantaku, Jianrong Dong, Chandrashekar R Ambati, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Nature Reviews. Urology|September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshopElaine Chang, Andrea B Apolo, Rick Bangs, et al.
The Journal of Urology|June 20, 2020
Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 InhibitorsGuru Sonpavde, Juliane Manitz, Chen Gao, et al.
JAMA Oncology|November 22, 2019
Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney CancerSundeep Agrawal, Naomi B Haas, Mohammadhadi Bagheri, et al.
Clinical Genitourinary Cancer|June 23, 2016
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial CarcinomaAndrea B Apolo, Fatima H Karzai, Jane B Trepel, et al.
AJR. American Journal of Roentgenology|October 16, 2019
Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective StudyBaris Turkbey, Marcin Czarniecki, Joanna H Shih, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2023
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer GroupAshish M Kamat, Andrea B Apolo, Marek Babjuk, et al.
JAMA Oncology|November 1, 2019
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder CancerAndrea B Apolo, Matthew I Milowsky, Lauren Kim, et al.
Urologic Oncology|August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancerMatthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2019
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder CancerVenkatrao Vantaku, Jianrong Dong, Chandrashekar R Ambati, et al.
Pageof 12